Recognition factors and nonspecific macrophage activation in the treatment of neoplastic disease.
D000818:Animals; D005947:Glucose / Q000031:analogs & derivatives; D006801:Humans; D007167:Immunotherapy; D007942:Leukemia, Experimental / Q000139:chemically induced / Q000473:pathology; D007951:Leukemia, Myeloid / Q000139:chemically induced / Q000473:pathology; D008264:Macrophages / Q000276:immunology*; D008748:Methylcholanthrene; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D011134:Polysaccharides / Q000627:therapeutic use; D000511:alpha-Macroglobulins / Q000627:therapeutic use*
D011134:Polysaccharides; D000511:alpha-Macroglobulins; D008748:Methylcholanthrene; D005947:Glucose